Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Jul 23 2024

· Issued by Zydus Lifesciences Limited

Filed with NSE · · 2 pages · English

Summary by 6ix AI

Zydus Lifesciences Limited has issued a press release announcing that it received final approval from the USFDA for Valsartan Tablets. The tablets are indicated for treating hypertension and heart failure in adults and pediatric patients. The drug will be manufactured at the company's facility in Ahmedabad SEZ - II, India.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases